IDH2 and central nervous system cancer: No correlation was found between P/LP variants and the IDH somatic mutation status (P/LP germline variants in 21.9% of patients with IDH-mutant gliomas versus 12.5% of patients with IDH-wildtype gliomas, two-tailed Fisher’s exact test, p = 0.7).